Evidence map›Paper›PMID 28741234›Full record

ArticleCurrent rheumatology reports2017

Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment.

Virginie Dufrost, Jessie Risse, Denis Wahl, Stéphane Zuily

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Current rheumatology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04262492 (OBServaToire INternational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04262492 recruitingnot on this mapstarted 2020, after this paper: background citation

OBServaToire INternational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

Typeobservational_patient_registrySponsorStéphane ZuilyRan2020 to 2031Enrolled500ConditionsAntiphospholipid Syndrome, Thrombosis, Anticoagulants Causing Adverse Effects in Therapeutic UseArmsRivaroxaban
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Virginie DufrostVascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.
Jessie RisseVascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.
Denis WahlVascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.
Stéphane ZuilyVascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France. s.zuily@chru-nancy.fr.
Inserm · FRUniversité de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiphospholipid SyndromeWarfarinAnticoagulantsHumansAnticoagulantsWarfarinAntiphospholipid antibodiesAntiphospholipid syndromeDirect oral anticoagulantsRivaroxabanThrombosisTriple positivity

Identifiers

PMID28741234
OpenAlexW2737224995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.